SCHEMBL13049673

SCHEMBL13049673

OCc1c(-c2nc3ccccc3o2)oc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.44
▸ HPGD P15428 6/20 0.44
▸ MAPT P10636 6/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ USP2 O75604 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ NPC1 O15118 8/20 0.44
▸ RAB9A P51151 7/20 0.44
▸ HSD17B10 Q99714 6/20 0.44
▸ TP53 P04637 4/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ PKM P14618 2/20 0.44
▸ HCRTR1 O43613 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ ATM Q13315 1/20 0.43
▸ ALOX5 P09917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3225774 0.76 ALDH1A1 (0.55) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL13049765 0.74 MEN1 (0.43) ALDH1A1HPGDMAPTKDM4ETDP1
SCHEMBL824375 0.74 NPC1 (0.69) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL29531707 0.74 NPC1 (0.69) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL2962849 0.74 KMT2A (0.53) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL4908248 0.73 TOP2A (0.54) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL13049721 0.72 MAPK14 (0.49) ALDH1A1HPGDKDM4EUSP2HSD17B10
SCHEMBL30096340 0.71 ALDH1A1 (0.65) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL29627559 0.71 ALDH1A1 (0.65) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL2493869 0.71 ALDH1A1 (0.56) ALDH1A1HPGDMAPTKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7837981-B2 Methods for imaging soluble A-beta GENERAL ELECTRIC COMPANY (US) 2010-11-23 — — US disclosed
US-7837981-B2 Methods for imaging soluble A-beta GENERAL ELECTRIC COMPANY (US) 2010-11-23 — — US disclosed
EP-1631561-B1 COMPOSITIONS AND METHODS FOR NON-INVASIVE IMAGING OF SOLUBLE BETA-AMYLOID GEN ELECTRIC (US) 2010-08-18 — — EP disclosed
US-7727511-B2 Agents for imaging soluble a-beta GENERAL ELECTRIC COMPANY (US) 2010-06-01 — — US disclosed
US-7727511-B2 Agents for imaging soluble a-beta GENERAL ELECTRIC COMPANY (US) 2010-06-01 — — US disclosed
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-08-16 — — US disclosed
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-08-16 — — US disclosed
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-06-21 — — US disclosed
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA APBA1, APP, FABP7 ALDH1A1 2902/4885HPGD 3422/4885MAPT 170/4885
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA APBA1, APP, FABP7 ALDH1A1 3108/4885HPGD 3338/4885MAPT 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback